aTyr Pharma (ATYR) Appoints Eric Benevich to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. COIN
4. PINS
5. RDDT
6. FSLR
7. SYK
8. DASH
9. SBUX
10. SNDK

Go back to aTyr Pharma (ATYR) Appoints Eric Benevich to its Board

aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors

December 12, 2024 4:00 PM EST

SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (aTyr or the Company), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced the appointment of Eric Benevich to the Companys Board of Directors, effective as of December 10, 2024. Mr. Benevich currently serves as Chief Commercial Officer at Neurocrine Biosciences, Inc. (Neurocrine).

We are excited to welcome Eric Benevich to the Board of Directors, said Timothy P. Coughlin, Chairman of the Board of aTyr. His extensive... More